$XERS

$10.21 +$0.01 (0.1%) Close

$XERS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$XERS Management Team

Mr. Kevin McCulloch

President

Chief Operating Officer

Age 62

Compensation $2.578M USD

Sex Male

Dr. Anh Nguyen

Chief Medical Officer

Age 50

Compensation -

Sex Male

Ms. Allison Wey

Senior Vice President - Investor Relations & Corporate Communications

Age -

Compensation -

Sex Female

Ms. Marla Persky

Independent Chairman of the Board

Age 69

Compensation $208.6K USD

Sex Female

Mr. John Shannon

Chief Executive Officer

Director

Age 63

Compensation $3.827M USD

Sex Male

Mr. Steven Pieper

Chief Financial Officer

Age 48

Compensation $1.854M USD

Sex Male

Ms. Beth Hecht

Chief Legal Officer

Corporate Secretary

Age 62

Compensation $2.613M USD

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Kevin McCulloch President Chief Operating Officer	62	$2.578M USD	Male
Dr. Anh Nguyen Chief Medical Officer	50	-	Male
Ms. Allison Wey Senior Vice President - Investor Relations & Corporate Communications	-	-	Female
Ms. Marla Persky Independent Chairman of the Board	69	$208.6K USD	Female
Mr. John Shannon Chief Executive Officer Director	63	$3.827M USD	Male
Mr. Steven Pieper Chief Financial Officer	48	$1.854M USD	Male
Ms. Beth Hecht Chief Legal Officer Corporate Secretary	62	$2.613M USD	Female

Board of Directors

From the proxy statement filed Apr 23, 2026

Directors

serving now

Independent

7 of 8

stated in the proxy

Average tenure

4.0 years

from year joined

CEO also chairs the board

Marla Persky

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Dawn Halkuff	55	2021 5 years	Independent	Compensation Committee	None stated	$290,500
John Johnson	68	2021 5 years	Independent	Nominating and Corporate Governance Committee	Verastem, Inc., AxoGen, Inc.	$276,500
John Shannon CEO	64	2024 2 years	Not independent	None stated	None stated	Paid as CEO
Marla Persky Board chair	70	2021 5 years	Independent	Audit Committee Nominating and Corporate Governance Committee	Revolo Biotherapeutics Limited	$326,500
BJ Bormann	67	2021 5 years	Independent	Nominating and Corporate Governance Committee	BioLine Rx Ltd., NanoMedical Systems Inc.	$294,500
James Brady	63	2025 1 year	Independent	None stated	None stated	$606,984
Garheng Kong	50	2021 5 years	Independent	Audit Committee	Laboratory Corporation of America Holdings, Lunit, Inc., Smith+Nephew	$281,500
Jeffrey Sherman Leaving at the meeting	Not stated	Not stated	Independent	Compensation Committee Nominating and Corporate Governance Committee	None stated	$285,500

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$XERS Management Team

Mr. Kevin McCulloch

Dr. Anh Nguyen

Ms. Allison Wey

Ms. Marla Persky

Mr. John Shannon

Mr. Steven Pieper

Ms. Beth Hecht

Board of Directors

Related-party transactions

No related-party transactions disclosed